FDA Approves Gene Therapy with ISCRM Origins
July 5, 2023 | Categories: Core Faculty, Research |The FDA has approved a first-ever gene therapy for Duchenne muscular dystrophy based in part on technology developed by UW Medicine/ISCRM Researchers Read More
Gene Therapy Cassettes Improved for Muscular Dystrophy
February 1, 2019 | Categories: Research |February 1, 2019 Experimental gene therapy cassettes for Duchenne muscular dystrophy have been modified to deliver better performance. The cassettes, which carry the therapy into muscle cells, contain newer versions […] Read More
Gene therapy treats muscle-wasting disease in dogs
February 15, 2017 | Categories: Research |Work on gene therapy is showing significant progress for restoring muscle strength and prolonging lives in dogs with a previously incurable, inherited neuromuscular disease. UW Medicine Institute for Stem Cell […] Read More
Mutations in genes that modify DNA packaging result in form of muscular dystrophy
November 19, 2012 | Categories: Research |November 19, 2012 A recent finding by medical geneticists sheds new light on how facioscapulohumeral muscular dystrophy develops and how it might be treated. More commonly known as FSHD, the […] Read More